Zoned Properties, Inc. — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that Zoned Properties, Inc. filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Revenue
Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2023 | Dec 31, 2023 | $2.89M | Mar 26, 2024 |
| FY2023 | Dec 31, 2022 | $2.66M | Mar 26, 2024 |
| FY2022 | Dec 31, 2021 | $1.82M | Mar 28, 2023 |
| FY2021 | Dec 31, 2020 | $1.22M | Mar 24, 2022 |
| FY2020 | Dec 31, 2019 | $1.26M | Mar 31, 2021 |
| FY2019 | Dec 31, 2018 | $1.24M | Mar 26, 2020 |
| FY2018 | Dec 31, 2017 | $2.11M | Mar 28, 2019 |
| FY2017 | Dec 31, 2016 | $1.85M | Mar 13, 2018 |
| FY2016 | Dec 31, 2015 | $1.42M | Mar 27, 2017 |
| FY2015 | Dec 31, 2014 | $467.9K | Mar 9, 2016 |
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($2.85M) | Apr 1, 2026 |
| FY2025 | Dec 31, 2024 | $574.0K | Apr 1, 2026 |
| FY2024 | Dec 31, 2023 | ($540.3K) | Mar 28, 2025 |
| FY2023 | Dec 31, 2022 | ($574.4K) | Mar 26, 2024 |
| FY2022 | Dec 31, 2021 | ($165.8K) | Mar 28, 2023 |
| FY2021 | Dec 31, 2020 | ($78.3K) | Mar 24, 2022 |
| FY2020 | Dec 31, 2019 | ($12.3K) | Mar 31, 2021 |
| FY2019 | Dec 31, 2018 | ($2.03M) | Mar 26, 2020 |
| FY2018 | Dec 31, 2017 | $1.38M | Mar 28, 2019 |
| FY2017 | Dec 31, 2016 | ($501.6K) | Mar 13, 2018 |
Operating Income
Profit from core business operations before interest expense and income taxes (also known as EBIT). Excludes non-operating items, making it a cleaner measure of operational efficiency than net income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($1.89M) | Apr 1, 2026 |
| FY2025 | Dec 31, 2024 | $1.10M | Apr 1, 2026 |
| FY2024 | Dec 31, 2023 | $169.2K | Mar 28, 2025 |
| FY2023 | Dec 31, 2022 | ($109.0K) | Mar 26, 2024 |
| FY2022 | Dec 31, 2021 | $44.7K | Mar 28, 2023 |
| FY2021 | Dec 31, 2020 | $37.7K | Mar 24, 2022 |
| FY2020 | Dec 31, 2019 | $715 | Mar 31, 2021 |
| FY2019 | Dec 31, 2018 | ($1.96M) | Mar 26, 2020 |
| FY2018 | Dec 31, 2017 | $697.2K | Mar 28, 2019 |
| FY2017 | Dec 31, 2016 | ($272.2K) | Mar 13, 2018 |
R&D Expense
Spending on research and development activities — developing new products, improving existing ones, or conducting basic research. High R&D relative to revenue is common in technology and pharmaceutical companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2011 | Dec 31, 2011 | $270.1K | Apr 11, 2012 |
Operating Cash Flow
Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $781.5K | Apr 1, 2026 |
| FY2025 | Dec 31, 2024 | $578.2K | Apr 1, 2026 |
| FY2024 | Dec 31, 2023 | $82.5K | Mar 28, 2025 |
| FY2023 | Dec 31, 2022 | $871.9K | Mar 26, 2024 |
| FY2022 | Dec 31, 2021 | $489.3K | Mar 28, 2023 |
| FY2021 | Dec 31, 2020 | $170.0K | Mar 24, 2022 |
| FY2020 | Dec 31, 2019 | $284.9K | Mar 31, 2021 |
| FY2019 | Dec 31, 2018 | $360.0K | Mar 26, 2020 |
| FY2018 | Dec 31, 2017 | $53.9K | Mar 28, 2019 |
| FY2017 | Dec 31, 2016 | ($3.1K) | Mar 13, 2018 |
Capital Expenditures (Capex)
Cash spent on acquiring or upgrading physical assets — property, equipment, and infrastructure. High capex businesses include manufacturing, telecom, and energy companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2024 | $6.5K | Apr 1, 2026 |
| FY2024 | Dec 31, 2023 | $1.1K | Mar 28, 2025 |
| FY2023 | Dec 31, 2022 | $3.8K | Mar 26, 2024 |
| FY2022 | Dec 31, 2021 | $2.6K | Mar 28, 2023 |
| FY2021 | Dec 31, 2020 | $923 | Mar 24, 2022 |
| FY2018 | Dec 31, 2017 | $2.6K | Mar 28, 2019 |
| FY2017 | Dec 31, 2016 | $2.5K | Mar 13, 2018 |
| FY2016 | Dec 22, 2016 | $2.13M | Mar 27, 2017 |
| FY2016 | Dec 31, 2015 | $7.0K | Mar 27, 2017 |
| FY2015 | Dec 31, 2014 | $47.8K | Mar 9, 2016 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $13.93M | Apr 1, 2026 |
| FY2025 | Dec 31, 2024 | $16.18M | Apr 1, 2026 |
| FY2024 | Dec 31, 2023 | $14.44M | Mar 28, 2025 |
| FY2023 | Dec 31, 2022 | $14.38M | Mar 26, 2024 |
| FY2022 | Dec 31, 2021 | $8.14M | Mar 28, 2023 |
| FY2021 | Dec 31, 2020 | $8.13M | Mar 24, 2022 |
| FY2020 | Dec 31, 2019 | $8.16M | Mar 31, 2021 |
| FY2019 | Dec 31, 2018 | $8.23M | Mar 26, 2020 |
| FY2018 | Dec 31, 2017 | $10.05M | Mar 28, 2019 |
| FY2017 | Dec 31, 2016 | $9.64M | Mar 13, 2018 |
Total Liabilities
All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $10.86M | Apr 1, 2026 |
| FY2025 | Dec 31, 2024 | $10.32M | Apr 1, 2026 |
| FY2024 | Dec 31, 2023 | $9.20M | Mar 28, 2025 |
| FY2023 | Dec 31, 2022 | $8.70M | Mar 26, 2024 |
| FY2022 | Dec 31, 2021 | $2.22M | Mar 28, 2023 |
| FY2021 | Dec 31, 2020 | $2.19M | Mar 24, 2022 |
| FY2020 | Dec 31, 2019 | $2.19M | Mar 31, 2021 |
| FY2019 | Dec 31, 2018 | $2.31M | Mar 26, 2020 |
| FY2018 | Dec 31, 2017 | $2.22M | Mar 28, 2019 |
| FY2017 | Dec 31, 2016 | $3.46M | Mar 13, 2018 |
Stockholders Equity
The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $3.07M | Apr 1, 2026 |
| FY2025 | Dec 31, 2024 | $5.86M | Apr 1, 2026 |
| FY2025 | Dec 31, 2023 | $5.24M | Apr 1, 2026 |
| FY2024 | Dec 31, 2022 | $5.68M | Mar 28, 2025 |
| FY2023 | Dec 31, 2021 | $5.92M | Mar 26, 2024 |
| FY2022 | Dec 31, 2020 | $5.94M | Mar 28, 2023 |
| FY2021 | Dec 31, 2019 | $5.97M | Mar 24, 2022 |
| FY2020 | Dec 31, 2018 | $5.92M | Mar 31, 2021 |
| FY2019 | Dec 31, 2017 | $7.83M | Mar 26, 2020 |
| FY2018 | Jan 1, 2017 | $6.18M | Mar 28, 2019 |
Retained Earnings
Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($18.49M) | Apr 1, 2026 |
| FY2025 | Dec 31, 2024 | ($15.64M) | Apr 1, 2026 |
| FY2024 | Dec 31, 2023 | ($16.21M) | Mar 28, 2025 |
| FY2023 | Dec 31, 2022 | ($15.67M) | Mar 26, 2024 |
| FY2022 | Dec 31, 2021 | ($15.10M) | Mar 28, 2023 |
| FY2021 | Dec 31, 2020 | ($14.93M) | Mar 24, 2022 |
| FY2020 | Dec 31, 2019 | ($14.85M) | Mar 31, 2021 |
| FY2019 | Dec 31, 2018 | ($14.84M) | Mar 26, 2020 |
| FY2018 | Dec 31, 2017 | ($12.82M) | Mar 28, 2019 |
| FY2017 | Dec 31, 2016 | ($14.19M) | Mar 13, 2018 |
Cash & Equivalents
Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2022 | Dec 31, 2022 | $4.34M | Mar 28, 2023 |
| FY2022 | Dec 31, 2021 | $1.19M | Mar 28, 2023 |
| FY2021 | Dec 31, 2020 | $699.3K | Mar 24, 2022 |
| FY2020 | Dec 31, 2019 | $639.8K | Mar 31, 2021 |
| FY2020 | Dec 31, 2018 | $354.9K | Mar 31, 2021 |
| FY2019 | Dec 31, 2017 | $824.2K | Mar 26, 2020 |
| FY2018 | Jan 1, 2017 | $366.0K | Mar 28, 2019 |
| FY2018 | Dec 31, 2016 | $366.0K | Mar 28, 2019 |
| FY2017 | Dec 31, 2015 | $1.28M | Mar 13, 2018 |
| FY2016 | Dec 31, 2014 | $1.07M | Mar 27, 2017 |
Long-Term Debt
Debt obligations due more than one year from the balance sheet date — bonds, term loans, and notes payable. High long-term debt relative to equity can signal elevated financial leverage.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $7.69M | Apr 1, 2026 |
| FY2024 | Dec 31, 2024 | $7.19M | Mar 28, 2025 |
EPS (Basic)
Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 0 | Apr 1, 2026 |
| FY2025 | Dec 31, 2024 | 0 | Apr 1, 2026 |
| FY2024 | Dec 31, 2023 | 0 | Mar 28, 2025 |
| FY2022 | Dec 31, 2022 | 0 | Mar 28, 2023 |
| FY2022 | Dec 31, 2021 | 0 | Mar 28, 2023 |
| FY2021 | Dec 31, 2020 | 0 | Mar 24, 2022 |
| FY2020 | Dec 31, 2019 | 0 | Mar 31, 2021 |
| FY2019 | Dec 31, 2018 | 0 | Mar 26, 2020 |
| FY2018 | Dec 31, 2017 | 0 | Mar 28, 2019 |
| FY2017 | Dec 31, 2016 | 0 | Mar 13, 2018 |
EPS (Diluted)
Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 0 | Apr 1, 2026 |
| FY2025 | Dec 31, 2024 | 0 | Apr 1, 2026 |
| FY2024 | Dec 31, 2023 | 0 | Mar 28, 2025 |
| FY2023 | Dec 31, 2022 | 0 | Mar 26, 2024 |
| FY2022 | Dec 31, 2021 | 0 | Mar 28, 2023 |
| FY2021 | Dec 31, 2020 | 0 | Mar 24, 2022 |
| FY2020 | Dec 31, 2019 | 0 | Mar 31, 2021 |
| FY2019 | Dec 31, 2018 | 0 | Mar 26, 2020 |
| FY2018 | Dec 31, 2017 | 0 | Mar 28, 2019 |
| FY2017 | Dec 31, 2016 | 0 | Mar 13, 2018 |
Shares Outstanding
Total common shares issued and held by all shareholders, excluding treasury shares. Combined with market price gives market capitalization.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 12.03M | Apr 1, 2026 |
| FY2025 | Dec 31, 2024 | 12.09M | Apr 1, 2026 |
| FY2024 | Dec 31, 2023 | 12.10M | Mar 28, 2025 |
| FY2023 | Dec 31, 2022 | 12.20M | Mar 26, 2024 |
| FY2022 | Dec 31, 2021 | 12.20M | Mar 28, 2023 |
| FY2021 | Dec 31, 2020 | 12.01M | Mar 24, 2022 |
| FY2020 | Dec 31, 2019 | 11.90M | Mar 31, 2021 |
| FY2019 | Dec 31, 2018 | 17.44M | Mar 26, 2020 |
| FY2018 | Dec 31, 2017 | 17.35M | Mar 28, 2019 |
| FY2017 | Dec 31, 2016 | 17.21M | Mar 13, 2018 |